Operating Lease, Payments in USD of RECURSION PHARMACEUTICALS, INC. from 2022 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Recursion Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and change rate from 2022 to Q1 2025.
  • Recursion Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $5.27M, a 33.1% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. annual Operating Lease, Payments for 2024 was $14.1M, a 42.9% increase from 2023.
  • Recursion Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $9.86M, a 38.7% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $5.27M +$1.31M +33.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 $3.96M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05

RECURSION PHARMACEUTICALS, INC. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14.1M +$4.23M +42.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $9.86M +$2.75M +38.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $7.11M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.